SenesTech (NASDAQ:SNES) Receives New Coverage from Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES) in a research note issued on Friday. The brokerage set a “sell” rating on the stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $35.00 price objective on shares of SenesTech in a report on Tuesday, May 14th.

SenesTech Trading Down 3.4 %

Shares of SNES opened at $3.06 on Friday. SenesTech has a 52 week low of $2.65 and a 52 week high of $78.00. The stock’s 50-day moving average price is $4.39 and its 200-day moving average price is $6.38. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.49 and a current ratio of 4.68.

SenesTech (NASDAQ:SNES) last released its quarterly earnings data on Thursday, August 8th. The company reported ($3.08) EPS for the quarter, topping the consensus estimate of ($3.20) by $0.12. The business had revenue of $0.46 million for the quarter, compared to analyst estimates of $0.49 million. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. During the same quarter in the prior year, the firm posted ($84.03) EPS. As a group, equities analysts predict that SenesTech will post -11 EPS for the current year.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.